Brooktree Capital Management
- SEC CIK
- 0001021296
- Latest filing
- Aug 5, 2026
DXCM holding history
Dexcom Inc in every 13F filed by Brooktree Capital Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings
- Shares (Q2 2026)
- 51,061
- Value
- $3.44M
- % of portfolio
- 2.2%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 51,061 | $3.44M | 2.2% | +783+1.6% | Added | Holders |
| Q1 2026 | 50,278 | $3.16M | 2.5% | +5,621+12.6% | Added | Holders |
| Q4 2025 | 44,657 | $2.96M | 2.0% | +2,777+6.6% | Added | Holders |
| Q3 2025 | 41,880 | $2.82M | 1.8% | +12,635+43.2% | Added | Holders |
| Q2 2025 | 29,245 | $2.55M | 1.7% | +13,713+88.3% | Added | Holders |
| Q1 2025 | 15,532 | $1.06M | 0.8% | +1,896+13.9% | Added | Holders |
| Q4 2024 | 13,636 | $1.06M | 0.8% | +3,453+33.9% | Added | Holders |
| Q3 2024 | 10,183 | $682.7K | 0.6% | +10,183 | New | Holders |